Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma	Recruiting	Phase 2	2025-02-07		NCT04586478

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Juventas Cell Therapy Ltd.	16

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Boren Hospital	Beijing	China	1
Beijing Cancer Hospital	Beijing	China	55
Guangdong Provincial Peoples' Hospital	Guangzhou	China	1
Henan Cancer Hospital	Zhengzhou	China	98
Institute of Hematology & Blood Diseases Hospital	Tianjin	China	24
Peking University Third Hospital	Beijing	China	38
Qilu Hospital of Shandong University	Jinan	China	68
Ruijin Hospital, Shanghai Jiaotong University School of Medicine	Shanghai	China	45
SunYat-sen University Cancer Center	Guangzhou	China	4
The First Affiliated Hospital of Chongqing Medical University	Chongqing	China	38
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	103
The First Affiliated Hospital, Zhejiang University School of Medicine	Hangzhou	China	29
Tianjin Medical University Cancer Institute & Hospital	Tianjin	China	23
Tongji Hospital Of Tongji University	Shanghai	China	4
Tongji Hospital, Tongji Medical College of Hust	Wuhan	China	2
West China Hospital，Sichuan University	Chengdu	China	12
Xinqiao Hospital of TMMU	Chongqing	China	1